Stone X Group Inc. Bristol Myers Squibb CO Transaction History

Stone X Group Inc.

$1.02 Billion
Q2 2024

A detailed history of Stone X Group Inc. transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Stone X Group Inc. holds 14,673 shares of BMY stock, worth $780,456. This represents 0.06% of its overall portfolio holdings.

Number of Shares

14,673

Previous 14,375 2.07%

Holding current value

$780,456

Previous $780,000 21.92%

% of portfolio

0.06%

Previous 0.09%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 07, 2024	BUY	$40.25 - $52.99 $11,994 - $15,791	298 Added 2.07%	14,673 $609,000
Q1 2024 May 01, 2024	BUY	$47.98 - $54.4 $27,972 - $31,715	583 Added 4.23%	14,375 $780,000
Q4 2023 Feb 12, 2024	SELL	$48.48 - $57.85 $500,071 - $596,722	-10,315 Reduced 42.79%	13,792 $708,000
Q3 2023 Nov 14, 2023	SELL	$57.89 - $64.73 $11,925 - $13,334	-206 Reduced 0.85%	24,107 $1.4 Million
Q2 2023 Aug 11, 2023	BUY	$63.71 - $70.74 $36,888 - $40,958	579 Added 2.44%	24,313 $1.56 Million
Q1 2023 May 11, 2023	BUY	$65.71 - $74.53 $40,674 - $46,134	619 Added 2.68%	23,734 $1.65 Million
Q4 2022 Feb 10, 2023	BUY	$68.48 - $81.09 $65,329 - $77,359	954 Added 4.3%	23,115 $1.66 Million
Q3 2022 Nov 08, 2022	BUY	$0.13 - $76.84 $27 - $16,290	212 Added 0.97%	22,161 $1.58 Million
Q2 2022 Jul 27, 2022	BUY	$72.62 - $79.98 $1.59 Million - $1.76 Million	21,949 New	21,949 $1.7 Million
Q1 2022 May 11, 2022	SELL	$61.48 - $73.72 $1.01 Million - $1.21 Million	-16,434 Closed	0 $0
Q4 2021 Feb 10, 2022	SELL	$53.63 - $62.52 $165,823 - $193,311	-3,092 Reduced 15.84%	16,434 $1.03 Million
Q3 2021 Oct 20, 2021	BUY	$59.17 - $69.31 $62,246 - $72,914	1,052 Added 5.69%	19,526 $1.17 Million
Q2 2021 Aug 06, 2021	BUY	$61.91 - $67.42 $67,481 - $73,487	1,090 Added 6.27%	18,474 $1.23 Million
Q1 2021 Jun 23, 2021	BUY	$59.34 - $66.74 $33,349 - $37,507	562 Added 3.34%	17,384 $1.1 Million
Q4 2020 Feb 03, 2021	BUY	$57.74 - $65.43 $6,582 - $7,459	114 Added 0.68%	16,822 $1.04 Million
Q3 2020 Nov 12, 2020	BUY	$57.43 - $63.64 $44,737 - $49,575	779 Added 4.89%	16,708 $1.01 Million
Q2 2020 Aug 12, 2020	SELL	$54.82 - $64.09 $1,754 - $2,050	-32 Reduced 0.2%	15,929 $936,000
Q1 2020 Apr 30, 2020	SELL	$46.4 - $67.43 $330,692 - $480,573	-7,127 Reduced 30.87%	15,961 $889,000
Q4 2019 Jan 24, 2020	BUY	$49.21 - $64.19 $1.14 Million - $1.48 Million	23,088 New	23,088 $1.48 Million
Q3 2017 Nov 13, 2017	SELL	$55.23 - $63.74 $382,633 - $441,590	-6,928 Closed	0 $0
Q2 2017 Aug 31, 2017	BUY	N/A	6,928	6,928 $386,000

Others Institutions Holding BMY

# of Institutions

2,428

Shares Held

1.5B

Call Options Held

29.7M

Put Options Held

32.2M

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $113B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Stone X Group Inc., based on Form 13F filings with the SEC.

News

Stay updated on Stone X Group Inc. with notifications on news.

Account